Long Read Sequencing Market by Product (Instruments, Consumables and Services), Technology, Workflow, Application, End User and Geography - Global Industry Analysis, Opportunities and Forecast up to 2026

The global long read sequencing market size was valued at $1,017.39 million in 2020, and is projected to reach $3,557.54 million by 2026, growing at a CAGR of 23.2% during the forecast period.

• The long read sequencing market is expected to witness significant growth in the future due to increasing application in clinical sequencing & analysis and rise in prevalence of genetic disorder.

• Additionally, an increase in investments by key players toward R&D related to long-read sequencing technologies, coupled with rise in prevalence of genetic disorders, is expected to create ample opportunities for the market significantly. The use of longer reads that originate from a single DNA molecule provides a distinctive advantage to long read sequencing methods over their counterparts.

• However, higher cost per base relative to short read sequencing is one of the factors restraining the market.

Long read sequencing, often known as third generation sequencing, is a technique for analysing large amounts of data. This is a method in which DNA molecules are sequenced directly in real time and lengthy reads are created as a result of this direct sequencing. These sequencing processes are frequently carried out without PCR amplification. Single molecule real time (SMRT) sequencing and nanopore sequencing are the two main techniques used in long read sequencing.

By Product, the Consumables Segment Emerges as the Dominant Segment

The Consumables segment emerges as the dominant segment during the forecast period. Consumables are further segmented into kits, probes and others. Ligation sequencing kits, quick / field sequencing kits, PCR sequencing kits, rapid PCR sequencing kits, 16s barcoding kits, direct RNA sequencing kits, direct cDNA sequencing kits, and others are among the kits available. Library preparation, sequencing, analysis, and other services are further divided. Consumables will account for the majority of the market in 2020. In order to undertake genome sequencing, end users must collect intervals on a frequent basis because they are used to running many sequences.

By Geography, North America Region Holds a Substantial Market Share

North America accounted for the largest share owing to factors such as local presence of leading market players such as Pacific Biosciences, reputable informatics network, and well-regulated framework for usage and approval of genomic tests in the region. Furthermore, the North American market is likely to be driven by an increase in the number of genomic operations for academic and clinical application in the United States over the forecast period. Throughout the projected period, Asia Pacific is expected to grow at the fastest rate. The regional market would be driven by increasing penetration of top companies in growing Asian countries and increased investments in the development of improved diagnostic procedures.

List of the Key Players Profiled in the Market Include:

• Agilent Technologies, Inc
• BaseClear B.V
• FG Technologies
• Genexa AG
• Illumina, Inc.
• Macrogen, Inc
• MicrobesNG
• Novogene Corporation
• Oxford Nanopore
• Pacific Biosciences of California, Inc.
• PerkinElmerInc
• Quantapore, Inc.
• Stratos Genomics (Hoffmann-La Roche Ltd.)
• Takara Bio Inc. (Takara Holdings Inc.)
• The Bordeaux Transcriptome Genome Platform
• Thermo Fisher Scientific, Inc

What Can be Explored with this Research Report:

• Understand the key trends that will drive the market, challenges it faces in the current market scenario.
• Identify growth opportunities.
• Porter’s five force analysis.
• In-depth analysis of market segments, and regions/countries predicted to observed promising growth.
• Historical and forecast size of the market in terms of revenue (USD Million).
• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product:
• Instruments
• Consumables
• Services
   
Market by, Technology:
• Single- Molecule Real- Time Sequencing
• Nanopore Sequencing
   
Market by, Workflow:
• Pre-sequencing
• Sequencing
• Data Analysis

Market by, Application:
• Identification & Fine Mapping Of Structural Variation
• Tandem Repeat Sequencing
• Pseudogene Discrimination
• Resolving Allele Phasing
• Reproductive Genomics
• Cancer
• Viral & Microbial Sequencing
• Other Applications

Market by, End User:
• Academic & Research Institutes
• Clinical Laboratories
• Hospitals
• Biotechnologies and Pharmaceutical Companies

Market by, Geography:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Table Of Content

1 Market Overview            
    1.1 Introduction        
    1.2 Research Objectives       
    1.3 Market Segmentation       
    1.4 Stakeholders        
    1.5 List of Acronyms        
               
2 Executive Summary            
              
3 Research Methodology           
    3.1 Identification of Data       
    3.2 Evaluation of Market Dynamics      
    3.3 Collaboration of Data       
    3.4 Verification and Analysis        
    3.5 Data Sources        
    3.6 Assumptions        
              
4 Market Dynamics            
    4.1 Market Drivers        
            4.1.1 Increasing application in clinical sequencing & analysis
            4.1.2 Rise in prevalence of genetic disorders
    4.2 Market Restraints        
            4.2.1 Rise in prevalence of genetic disorders
    4.3 Impact of COVID-19 on Long Read Sequencing Market    
              
5 Porter's Five Force Analysis           
    5.1 Bargaining Power of Suppliers       
    5.2 Bargaining Power of Buyers       
    5.3 Threat of New Entrants       
    5.4 Threat of Substitutes       
    5.5 Competitive Rivalry in the Market      
              
6 Global Long Read Sequencing Market by, Product         
    6.1 Overview        
    6.2 Instruments        
    6.3 Consumables        
    6.4 Services         
              
7 Global Long Read Sequencing Market by, Technology        
    7.1 Overview        
    7.2 Single- Molecule Real- Time Sequencing      
    7.3 Nanopore Sequencing       
              
8 Global Long Read Sequencing Market by, Workflow        
    8.1 Overview        
    8.2 Pre-sequencing        
    8.3 Sequencing        
    8.4 Data Analysis        
               
9 Global Long Read Sequencing Market by, Application        
    9.1 Overview        
    9.2 Identification & Fine Mapping Of Structural Variation    
    9.3 Tandem Repeat Sequencing       
    9.4 Pseudogene Discrimination       
    9.5 Resolving Allele Phasing       
    9.6 Reproductive Genomics       
    9.7 Cancer         
    9.8 Viral & Microbial Sequencing       
    9.9 Other Applications        
              
10 Global Long Read Sequencing Market by, End User         
    10.1 Overview        
    10.2 Academic & Research Institutes      
    10.3 Clinical Laboratories       
    10.4 Hospitals         
    10.5 Biotechnologies and Pharmaceutical Companies     
              
11 Global Long Read Sequencing Market by, Geography        
    11.1 Overview        
    11.2 North America        
    11.3 Europe US        
    11.4 Asia Pacific Canada        
    11.5 South America Mexico        
    11.6 Middle East & Africa       
              
12 Key Developments            
              
13 Company Profiling            
    13.1 Agilent Technologies, Inc       
            13.1.1 Business Overview
            13.1.2 Product/Service Offering
            13.1.3 Financial Overview
            13.1.4 SWOT Analysis
            13.1.5 Key Activities
    13.2 BaseClear B.V        
    13.3 FG Technologies        
    13.4 Genexa AG        
    13.5 Illumina, Inc.        
    13.6 Macrogen, Inc        
    13.7 MicrobesNG        
    13.8 Novogene Corporation       
    13.9 Oxford Nanopore        
    13.10 Pacific Biosciences of California, Inc.      
    13.11 PerkinElmerInc        
    13.12 Quantapore, Inc.        
    13.13 Stratos Genomics (Hoffmann-La Roche Ltd.)     
    13.14 Takara Bio Inc. (Takara Holdings Inc.)      
    13.15 The Bordeaux Transcriptome Genome Platform     
    13.16 Thermo Fisher Scientific, Inc